Caricamento...
Safety analysis of Ziagen® (abacavir sulfate) in postmarketing surveillance in Japan†
PURPOSE: Abacavir is a nucleoside reverse transcriptase inhibitor indicated for human immunodeficiency virus (HIV) infection. In Japan, Ziagen® (300-mg abacavir sulfate) has been marketed since 1999. To obtain safety data on Ziagen, a mandatory postmarketing surveillance was conducted between Septem...
Salvato in:
| Pubblicato in: | Pharmacoepidemiol Drug Saf |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Blackwell Publishing Ltd
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4230480/ https://ncbi.nlm.nih.gov/pubmed/24585486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.3589 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|